Maccura Biotech to reduce capital after shareholder meeting

Maccura Biotechnology (SZSE:300463) announced that resolutions were passed at its Second Extraordinary General Meeting of Shareholders held on June 27, 2025, concerning a reduction in registered capital. These resolutions include terminating the 2024 Restricted Stock Incentive Plan, which involves the cancellation of certain restricted shares. Specifically, 3,844,966 shares previously allocated for the terminated incentive plan will be repurchased and cancelled.